238 related articles for article (PubMed ID: 30386303)
1. SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease.
Zhong Y; Lee K; He JC
Front Endocrinol (Lausanne); 2018; 9():624. PubMed ID: 30386303
[TBL] [Abstract][Full Text] [Related]
2. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.
Hong Q; Zhang L; Das B; Li Z; Liu B; Cai G; Chen X; Chuang PY; He JC; Lee K
Kidney Int; 2018 Jun; 93(6):1330-1343. PubMed ID: 29477240
[TBL] [Abstract][Full Text] [Related]
3. Role of transcription factor acetylation in diabetic kidney disease.
Liu R; Zhong Y; Li X; Chen H; Jim B; Zhou MM; Chuang PY; He JC
Diabetes; 2014 Jul; 63(7):2440-53. PubMed ID: 24608443
[TBL] [Abstract][Full Text] [Related]
4. SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy.
Ji J; Tao P; Wang Q; Li L; Xu Y
Endocr Metab Immune Disord Drug Targets; 2021; 21(5):835-842. PubMed ID: 33121427
[TBL] [Abstract][Full Text] [Related]
5. Reduction in podocyte SIRT1 accelerates kidney injury in aging mice.
Chuang PY; Cai W; Li X; Fang L; Xu J; Yacoub R; He JC; Lee K
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F621-F628. PubMed ID: 28615249
[TBL] [Abstract][Full Text] [Related]
6. Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway.
Liu H; Wang J; Yue G; Xu J
Ren Fail; 2024 Dec; 46(1):2303396. PubMed ID: 38234193
[TBL] [Abstract][Full Text] [Related]
7. Additive renal protective effects between arctigenin and puerarin in diabetic kidney disease.
Li X; Wang J; Yan J; He JC; Li Y; Zhong Y
Biomed Pharmacother; 2024 Feb; 171():116107. PubMed ID: 38215692
[TBL] [Abstract][Full Text] [Related]
8. Role of SIRT1 in HIV-associated kidney disease.
Wang X; Liu R; Zhang W; Hyink DP; Das GC; Das B; Li Z; Wang A; Yuan W; Klotman PE; Lee K; He JC
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F335-F344. PubMed ID: 32657157
[TBL] [Abstract][Full Text] [Related]
9. SIRT1-dependent deacetylation of Txnip H3K9ac is critical for exenatide-improved diabetic kidney disease.
Wang MJ; Cai X; Liang RY; Zhang EM; Liang XQ; Liang H; Fu C; Zhou AD; Shi Y; Xu F; Cai MY
Biomed Pharmacother; 2023 Nov; 167():115515. PubMed ID: 37742607
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Regulation Through SIRT1 in Podocytes.
Nakatani Y; Inagi R
Curr Hypertens Rev; 2016; 12(2):89-94. PubMed ID: 26931472
[TBL] [Abstract][Full Text] [Related]
11. Puerarin Attenuates Diabetic Nephropathy by Promoting Autophagy in Podocytes.
Li X; Zhu Q; Zheng R; Yan J; Wei M; Fan Y; Deng Y; Zhong Y
Front Physiol; 2020; 11():73. PubMed ID: 32116781
[TBL] [Abstract][Full Text] [Related]
12. Puerarin attenuates diabetic kidney injury through interaction with Guanidine nucleotide-binding protein Gi subunit alpha-1 (Gnai1) subunit.
Zhu Q; Yang S; Wei C; Lu G; Lee K; He JC; Liu R; Zhong Y
J Cell Mol Med; 2022 Jul; 26(14):3816-3827. PubMed ID: 35678269
[TBL] [Abstract][Full Text] [Related]
13. Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease.
Zhang XJ; Liu CC; Li ZL; Ding L; Zhou Y; Zhang DJ; Zhang Y; Hou ST; Ma RX
Diabetol Metab Syndr; 2024 Feb; 16(1):40. PubMed ID: 38341600
[TBL] [Abstract][Full Text] [Related]
14. Low expression of HIV genes in podocytes accelerates the progression of diabetic kidney disease in mice.
Feng J; Bao L; Wang X; Li H; Chen Y; Xiao W; Li Z; Xie L; Lu W; Jiang H; Lee K; He JC
Kidney Int; 2021 Apr; 99(4):914-925. PubMed ID: 33359498
[TBL] [Abstract][Full Text] [Related]
15. The Role of SIRT1 in Diabetic Kidney Disease.
Yacoub R; Lee K; He JC
Front Endocrinol (Lausanne); 2014; 5():166. PubMed ID: 25346724
[TBL] [Abstract][Full Text] [Related]
16. From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.
Chou HC; Wen LL; Chang CC; Lin CY; Jin L; Juan SH
Toxicol Sci; 2017 Dec; 160(2):217-229. PubMed ID: 28973641
[TBL] [Abstract][Full Text] [Related]
17. Role of SIRT-1 as a Target for Treatment and Prevention of Diabetic Nephropathy: A Review.
Kumari A; Sodum N; Ravichandiran V; Kumar N
Curr Mol Pharmacol; 2023; 16(8):811-831. PubMed ID: 36624644
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.
Kim DH; Jung YJ; Lee JE; Lee AS; Kang KP; Lee S; Park SK; Han MK; Lee SY; Ramkumar KM; Sung MJ; Kim W
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F427-35. PubMed ID: 21593185
[TBL] [Abstract][Full Text] [Related]
19. The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.
Kravets I; Mallipattu SK
J Endocr Soc; 2020 Apr; 4(4):bvaa029. PubMed ID: 32232184
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells.
Jung YJ; Lee JE; Lee AS; Kang KP; Lee S; Park SK; Lee SY; Han MK; Kim DH; Kim W
Biochem Biophys Res Commun; 2012 Mar; 419(2):206-10. PubMed ID: 22330808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
